US HB7845 | 2021-2022 | 117th Congress
Status
Spectrum: Moderate Partisan Bill (Democrat 4-1)
Status: Introduced on May 19 2022 - 25% progression, died in committee
Action: 2022-05-20 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on May 19 2022 - 25% progression, died in committee
Action: 2022-05-20 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To direct the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health, to take certain steps to increase clinical trial diversity, and for other purposes.
Title
NIH Clinical Trial Diversity Act of 2022
Sponsors
| Rep. Robin Kelly [D-IL] | Rep. Brian Fitzpatrick [R-PA] | Rep. Tony Cardenas [D-CA] | Rep. G. Butterfield [D-NC] |
| Rep. Yvette Clarke [D-NY] |
History
| Date | Chamber | Action |
|---|---|---|
| 2022-05-20 | House | Referred to the Subcommittee on Health. |
| 2022-05-19 | House | Referred to the House Committee on Energy and Commerce. |
| 2022-05-19 | House | Introduced in House |
Same As/Similar To
SB4486 (Related) 2022-06-23 - Read twice and referred to the Committee on Finance.
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/117th-congress/house-bill/7845/all-info |
| Text | https://www.congress.gov/117/bills/hr7845/BILLS-117hr7845ih.pdf |
